Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells. (Q53386780)

13 May 2018

title

Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells. (English)

1 reference

13 May 2018

1 reference

John F Timms

1

1 reference

13 May 2018

Sarah L White

series ordinal

2

1 reference

13 May 2018

Michael J O'Hare

series ordinal

3

1 reference

13 May 2018

Michael D Waterfield

series ordinal

4

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 September 2002

1 reference

13 May 2018

published in

Oncogene

1 reference

13 May 2018

volume

21

1 reference

13 May 2018

issue

43

1 reference

13 May 2018

page(s)

6573-6586

1 reference

13 May 2018

Proteasome inhibition: a new strategy in cancer treatment

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

21 January 2018

Myc and the cell cycle

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Distinct Tyrosine Autophosphorylation Sites Negatively and Positively Modulate Neu-Mediated Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Multiple ras effector pathways contribute to G(1) cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

New model of ErbB-2 over-expression in human mammary luminal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Ras enhances Myc protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

Cyclin D1 protein expression and function in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1)

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1205847

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205847

1 reference

13 May 2018

1 reference

13 May 2018